The heat shock protein 90 inhibitor RGRN-305 attenuates SARS-CoV-2 spike protein-induced inflammation in vitro but lacks effectiveness as COVID-19 treatment in mice.
Saved in:
| Title: | The heat shock protein 90 inhibitor RGRN-305 attenuates SARS-CoV-2 spike protein-induced inflammation in vitro but lacks effectiveness as COVID-19 treatment in mice. |
|---|---|
| Authors: | Ben Abdallah, Hakim1 (AUTHOR) hba@clin.au.dk, Marino, Giorgia2 (AUTHOR), Idorn, Manja2 (AUTHOR), S. Reinert, Line2 (AUTHOR), Bregnhøj, Anne1 (AUTHOR), Paludan, Søren Riis2 (AUTHOR), Johansen, Claus1 (AUTHOR) |
| Source: | PLoS ONE. 9/26/2024, Vol. 19 Issue 9, p1-13. 13p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 19326203 |
|---|---|
| DOI: | 10.1371/journal.pone.0310915 |
